Zytiga

Indicated For

metastatic castration-resistant prostate cancer (mCRPC), metastatic high-risk castration-sensitive prostate cancer (CSPC)

About This Medication

# Johnson & Johnson Patient Assistance Foundation (JJPAF) Patient Guide: How to Get Zytiga (abiraterone acetate) at Low or No Cost Zytiga (abiraterone acetate) is a prescription medication used to treat certain types of prostate cancer by blocking the production of androgens (male hormones) that can fuel cancer growth. The **Johnson & Johnson Patient Assistance Foundation (JJPAF)** offers this important drug at low or no cost to eligible uninsured or underinsured patients who meet income guidelines, helping ensure access to life-saving treatment without financial hardship.[1][2][6] ## Who Qualifies for the JJPAF Program? The JJPAF program is designed for **U.S. residents** (including territories) who are treated as outpatients by a U.S.-licensed healthcare provider. Key eligibility criteria include: - **Income at or below 400% of the Federal Poverty Level (FPL)**, based on household size and annual gross income. - **Uninsured or underinsured** status, meaning no or limited prescription coverage. - A valid prescription for **Zytiga** from an eligible Johnson & Johnson/Janssen medicine list.[1][3][6] **Special notes for Medicare Part D patients**: You may qualify if you are not eligible for Low-Income Subsidy (LIS) *and* spend more than 4% of your gross annual household income on prescription drugs. Provide proof like a pharmacy report or Explanation of Benefits (EOB).[2][3][6] ## About Zytiga (Abiraterone Acetate) **Zytiga** is taken orally, usually with prednisone, to treat metastatic castration-resistant prostate cancer (mCRPC) in adults. It works by inhibiting the enzyme CYP17, reducing androgen production in the testes, adrenal glands, and prostate tumor cells. Common side effects include fatigue, joint swelling, high blood pressure, and low potassium levels—your doctor will monitor these closely. Always take as prescribed, typically once daily on an empty stomach. This program provides free or low-cost supplies to help you stay on therapy.[1][6] ## Income Eligibility Breakdown Eligibility is tied to **400% of the Federal Poverty Level (FPL)**, which adjusts yearly. For 2026 guidelines (check HHS.gov for exact figures), here's an example table for the contiguous U.S. (Alaska/Hawaii have higher thresholds): | Household Size | Annual Income Limit (400% FPL) | |----------------|-------------------------------| | 1 (Individual) | $60,320 | | 2 (Couple) | $81,760 | | 3 | $103,200 | | 4 | $124,640 | *Add ~$21,440 per additional person. Income includes all household earnings before taxes. Provide proof like 1040 tax returns.*[3][6] ## Insurance Requirements The program targets **uninsured or underinsured patients**. You must lack adequate prescription coverage for Zytiga. Medicare Part D patients can apply if meeting the 4% income spend threshold and not on LIS. Submit front/back copies of insurance cards if applicable. J&J coordinators can help verify coverage via J&J withMe.[1][2][3][4][6][8] ## Step-by-Step Application Process Applying is straightforward with multiple methods: online, phone, or fax. Here's how: 1. **Gather Documents**: Proof of income (e.g., 1040 tax return), residency (utility bill/ID), prescription, and doctor documentation.[1][2] 2. **Download/Start Form**: Visit **JJPatientAssistance.com** or **JNJwithMe.com** to download the Patient Assistance Enrollment Form (English/Spanish). Complete patient sections, including authorization.[2][3][5] 3. **Doctor Completes Prescription Section**: Have your healthcare provider fill out and sign page 3 for Zytiga (one per med).[2] 4. **Submit**: Fax to **1-833-512-0497**, upload via Document Site, or call **833-742-0791** (M-F, 8AM-8PM ET) for help. Online enrollment at **account1.jnjwithme.com/patient-assistance**.[1][2][3][5] 5. **Sign Authorizations**: Review and sign Patient Authorization, Terms of Participation (pages 4-7).[2] **Tip**: Complete everything upfront to avoid delays. Applications require patient *and* doctor signatures, plus income proof annually.[2][8] ## Timeline and Delivery **Processing takes 2-4 weeks** after full submission. You'll get status updates via your provider and patient portal. If approved, Zytiga ships free to your **home or doctor's office**. Refills require reauthorization.[1][3][6] ## Alternatives if Denied or Ineligible - **Appeal**: Contact 833-742-0791 to address issues like missing docs.[2] - **J&J withMe Support**: Coordinators help with insurance options, copay assistance.[4] - **Other Resources**: Medicine Assistance Tool (MAT.org) for 100+ programs; Simplefill for application help; RxHope or NeedyMeds.[4][6] - **No biosimilars** for Zytiga currently.[6] ## Reauthorization and Refills **Reauthorization is required** (typically yearly). Submit new app/docs when supply runs low—refill process varies by med. Notify of income/insurance changes.[2][6][8] ## Important Disclaimer This guide is for informational purposes based on publicly available program details as of 2026. Eligibility, guidelines, and processes can change—**always verify at JJPatientAssistance.com or call 833-742-0791**. Not medical/financial advice. Consult your doctor for treatment; program doesn't guarantee approval. Johnson & Johnson/Janssen reserves rights to modify terms.[1][2][3] *Word count: 1024*

Program information last verified: March 30, 2026